Concepedia

Tobias De Villiers

TD

Statistics

Publications

4

Citations

330

H-Index

4

Active since

2013

Affiliations

Stellenbosch University(Current)

Centro Paulista de Investigação Clinica

Merck & Co., Inc., Rahway, NJ, USA (United States)

Inserm

Bone Health and Osteoporosis Foundation

Tobias De Villiers is an author at Stellenbosch University specializing in postmenopausal osteoporosis treatment, osteoporosis, and bone health.

Publications per year

2013–2021

4

Publications

4

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

, , +10

Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial

Jacques P. Brown, Klaus Engelke, Tony M. Keaveny et al. · Journal of Bone and Mineral Research · 2021 · 73 citations · Full text

, , +16

Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial

Sydney Lou Bonnick, Tobias De Villiers, Alberto Odio et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 59 citations

, , +14

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension

Robert R. Recker, David W. Dempster, Bente Langdahl et al. · Journal of Bone and Mineral Research · 2020 · 29 citations · Full text

, , +16

1–4 of 4